๐ฌDeep Research
ALEC โ Alector Inc ยท catalysts, narrative & risks
Snapshot (as of Oct 2, 2026)
Alector Inc. (NASDAQ: ALEC) closed at ~$1.81, down 2.69% that session, with a market cap of ~$202M and a 52-week range of $1.09โ$3.40 [21], [22], [23]. This matches the on-file data (healthcare/biotechnology, ~$206.57M market cap) [20], [23]. The company is a clinical-stage biotech building its strategy around the Alector Brain Carrier (ABC) blood-brain barrier platform [24].
Recent catalysts (last ~1โ3 months)
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ